Improved Tumor Staging in Colorectal Cancer
- 23 July 1998
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (4) , 264-265
- https://doi.org/10.1056/nejm199807233390410
Abstract
Successful treatment is available for many neoplasms, but patients with cancer often die despite therapy because of a disseminated tumor that was not detected at the time of diagnosis. Surgery alone is sometimes enough to cure a patient with a solid tumor, but many patients who relapse might have been cured if they had been given additional treatment, such as radiotherapy or chemotherapy. The selection of patients who would benefit most from adjuvant therapy is crucial because of the side effects of the additional treatment.Colorectal cancer is perhaps the best example of a neoplasm in which stage and prognosis . . .Keywords
This publication has 7 references indexed in Scilit:
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998
- The use of RT‐PCR for prostate‐specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancerBritish Journal of Urology, 1996
- Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.Journal of Clinical Oncology, 1995
- The use of prognostic markers in surgery for colorectal cancerEuropean Journal Of Cancer, 1995
- Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?International Journal of Cancer, 1995
- Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.Journal of Clinical Oncology, 1994